Investment
Features
FeesSafety
Academy
More
Pluang+

Compare PBF Energy Inc. Class A Common Stock (PBF) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

PBF Energy Inc. Class A Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

PBF Energy Inc. Class A Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? PBF Energy Inc. Class A Common Stock trades at $89.57 (market cap $10.81B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: PBF Energy Inc. Class A Common Stock is far larger — about 6× Vir Biotechnology Inc. Common Stock's market cap, and PBF Energy Inc. Class A Common Stock pays a 1.21% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold PBF Energy Inc. Class A Common Stock for 1 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

PBFVIR
Market Cap
$10.81B$1.80B
Volume
3,399,9801,782,836
Sector
EnergyHealth
52-Week High
$91.17$11.78
52-Week Low
$26.02$5.12
Typical Hold Time
1 Days0 Days
Enterprise Value
$12.43B$1.36B
Dividend Yield
1.21%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

PBF Energy Inc. Class A Common Stock

PBF Energy trades at $91.17, up 7.23% in the last 24 hours and near its 52-week high, reflecting strong bullish momentum. The stock shows robust technical strength with a bullish moving average signal and trades above key support levels. Fundamentally, the company is transitioning from a net loss of $158.5 million in 2025 to a projected net profit of $1.4 billion in 2026, driven by restored refinery operations and significant debt reduction. Recent earnings beats, including a Q2 2026 EPS of $6.22 versus $4.15 expected, highlight operational improvements.

The outlook for PBF is positive with strong earnings growth and discounted valuation metrics, but risks include volatile refining margins and geopolitical influences on oil prices. Analyst sentiment is mixed with a consensus price target of $88.75, below the current price, suggesting caution despite the bullish technical setup. Investors should weigh the strong profitability rebound against potential headwinds from energy market fluctuations.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PBF
57% Buy43% Sell
Avg holding period · 1 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About PBF Energy Inc. Class A Common Stock

PBF Energy refines and markets petroleum products, including gasoline, diesel, and jet fuel. It also operates logistics assets supporting its refining business.

Read more on PBF →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →